The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.

Autor: Norquist BM, Garcia RL, Allison KH, Jokinen CH, Kernochan LE, Pizzi CC, Barrow BJ, Goff BA, Swisher EM, Norquist, Barbara M, Garcia, Rochelle L, Allison, Kimberly H, Jokinen, Chris H, Kernochan, Lauren E, Pizzi, Catherine C, Barrow, Bethany J, Goff, Barbara A, Swisher, Elizabeth M

Publikováno v: Cancer (0008543X); 11/15/2010, Vol. 116 Issue 22, p5261-5271, 11p

Long-read DNA and cDNA sequencing identify cancer-predisposing deep intronic variation in tumor-suppressor genes.

Autor: Gulsuner S; Departments of Medicine (Medical Genetics) and Genome Sciences, University of Washington, Seattle, Washington 98195-7720, USA., AbuRayyan A; Departments of Medicine (Medical Genetics) and Genome Sciences, University of Washington, Seattle, Washington 98195-7720, USA., Mandell JB; Departments of Medicine (Medical Genetics) and Genome Sciences, University of Washington, Seattle, Washington 98195-7720, USA., Lee MK; Departments of Medicine (Medical Genetics) and Genome Sciences, University of Washington, Seattle, Washington 98195-7720, USA., Bernier GV; UW Medicine-Valley Medical Center, Renton, Washington 98055, USA., Norquist BM; Division of Gynecologic Oncology, University of Washington, Seattle, Washington 98195, USA., Pierce SB; Departments of Medicine (Medical Genetics) and Genome Sciences, University of Washington, Seattle, Washington 98195-7720, USA., King MC; Departments of Medicine (Medical Genetics) and Genome Sciences, University of Washington, Seattle, Washington 98195-7720, USA; mcking@uw.edu., Walsh T; Departments of Medicine (Medical Genetics) and Genome Sciences, University of Washington, Seattle, Washington 98195-7720, USA.

Publikováno v: Genome research [Genome Res] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.

Prevention of Ovarian Cancer: Where are We Now and Where are We Going?

Autor: Rodriguez IV; Department of Obstetrics and Gynecology, University of Washington, NE Pacific ST, Box 356460, Seattle, WA, 98195-6460, USA., Ghezelayagh T; Department of Obstetrics and Gynecology, Stanford University, Palo Alto, CA, USA., Pennington KP; Alaska Women's Cancer Care, 3851 Piper St Ste U264, Anchorage, AK, 99508, USA., Norquist BM; Department of Obstetrics and Gynecology, University of Washington, NE Pacific ST, Box 356460, Seattle, WA, 98195-6460, USA. bnorquis@uw.edu.

Publikováno v: Current oncology reports [Curr Oncol Rep] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.

Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer.

Autor: Manchanda R; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK.; 3Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; 4MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, Faculty of Population Health Sciences, University College London, London, UK.; 5Department of Gynecology, All India Institute of Medical Sciences, New Delhi, India., Sun L; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 3Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK., Sobocan M; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK.; 6Division of Gynecology and Perinatology, University Medical Centre Maribor, Maribor, Slovenia., Rodriguez IV; 7Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA., Wei X; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 3Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK., Kalra A; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Oxley S; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Sideris M; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Fierheller CT; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Morgan RD; 8Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Chandrasekaran D; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK., Rust K; 9Institute of Genetics and Cancer, Cancer Research UK Edinburgh Centre, University of Edinburgh, Scotland, UK., Spiliopoulou P; 10School of Cancer Sciences, University of Glasgow, Scotland, UK., Miller RE; 11Department of Medical Oncology, Barts Health NHS Trust, London, UK., Crusz SM; 11Department of Medical Oncology, Barts Health NHS Trust, London, UK., Lockley M; 12Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK., Singh N; 13Department of Pathology, Barts Health NHS Trust, London, UK., Faruqi A; 13Department of Pathology, Barts Health NHS Trust, London, UK., Casey L; 13Department of Pathology, Barts Health NHS Trust, London, UK., Brockbank E; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Phadnis S; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Mills-Baldock T; 14Department of Medical Oncology, Barking, Havering, and Redbridge University Hospitals, Essex, UK., El-Khouly F; 14Department of Medical Oncology, Barking, Havering, and Redbridge University Hospitals, Essex, UK., Jenkins LA; 15North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK., Wallace A; 16Manchester Centre for Genomic Medicine, Division of Evolution, Infection, and Genomic Sciences, University of Manchester, Manchester, UK., Ahmed M; 15North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK., Kumar A; 15North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK., Swisher EM; 7Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA., Gourley C; 9Institute of Genetics and Cancer, Cancer Research UK Edinburgh Centre, University of Edinburgh, Scotland, UK., Norquist BM; 7Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA., Evans DG; 16Manchester Centre for Genomic Medicine, Division of Evolution, Infection, and Genomic Sciences, University of Manchester, Manchester, UK., Legood R; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 3Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Apr 18; Vol. 22 (2 D). Date of Electronic Publication: 2024 Apr 18.

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.

Autor: Nebgen DR; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Domchek SM; Basser Center for BRCA, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kotsopoulos J; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada., de Hullu JA; Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, The Netherlands., Crosbie EJ; Division of Cancer Sciences, University of Manchester, St Mary's Hospital, Manchester, UK., Paramanandam VS; Department of Obstetrics and Gynaecology, The Royal Women's Hospital, The University of Melbourne, Melbourne, Victoria, Australia., Brood-van Zanten MMA; Department of Gynecology, The Netherlands Cancer Institute, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Norquist BM; Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA., Guise T; Department of Endocrine Neoplasia and Hormone Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rozenberg S; Department of Obstetrics and Gynaecology, Universite Libre de Bruxelles, Brussels, Belgium., Kurian AW; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA., Pederson HJ; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Yuksel N; Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada., Michaelson-Cohen R; Department of Gynaecology and Medical Genetics Institute, Hebrew University Faculty of Medicine, Shaare Zedek Medical Centre, Jerusalem, Israel., Bober SL; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., da Silva Filho AL; Departamento de Ginecologia e Obstetricia da UFMG, Federal University of Minas Gerais, Belo Horizonte, Brazil., Johansen N; Department of Gynaecology and Obstetrics, Sørlandet Hospital HF Arendal, Arendal, Norway., Guidozzi F; Deparment of Obstetrics and Gynaecology, University of Witwatersrand, Johanesburg, South Africa., Evans DG; University of Manchester, Prevent Breast Cancer Centre, Manchester, UK., Menon U; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Kingsberg SA; University Hospitals Cleveland Medical Center, Case Western University School of Medicine, Cleveland, Ohio, USA., Powell CB; Kaiser Permanente Northern California, Hereditary Cancer Program, San Francisco, California, USA., Grandi G; Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy., Marchetti C; Department of Women's and Children's Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Catholic University Sacred Heart, Rome, Italy., Jacobson M; Women's College Hospital and Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada., Brennan DJ; UCD Gynaecological Oncology Group, UCD School of Medicine, Mater University Hospital, Dublin, Ireland., Hickey M; Department of Obstetrics and Gynaecology, Research Precinct, Level 7, The Royal Women's Hospital, University of Melbourne, Parkville, Victoria, Australia.

Publikováno v: BJOG : an international journal of obstetrics and gynaecology [BJOG] 2023 Nov; Vol. 130 (12), pp. 1437-1450. Date of Electronic Publication: 2023 May 02.